Periorbital myxedema treated with intralesional hyaluronidase

PURPOSE: Periorbital myxedema is one the most challenging symptoms for patients with Graves' eye disease (GED). The treatment of this condition is complex and often unsatisfactory. This case demonstrates the use of intralesional hyaluronidase to treat cosmetically concerning periorbital myxedem...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindgren, Aleksandra L., Sidhu, Sharleen, Welsh, Kathleen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262547/
https://www.ncbi.nlm.nih.gov/pubmed/32490285
http://dx.doi.org/10.1016/j.ajoc.2020.100751
Descripción
Sumario:PURPOSE: Periorbital myxedema is one the most challenging symptoms for patients with Graves' eye disease (GED). The treatment of this condition is complex and often unsatisfactory. This case demonstrates the use of intralesional hyaluronidase to treat cosmetically concerning periorbital myxedema. OBSERVATIONS: Follow up showed no clinically significant recurrence of myxedema over one year. CONCLUSION: Intralesional hyaluronidase represented an effective and safe treatment of periorbital myxedema in a patient with Graves' eye disease.

Ejemplares similares